A B S T R A C T Few studies have been published on peptide hydrolase activities of human small intestine mucosa. We developed methods to screen tissue extracts for such enzymes and to quantitate hydrolase activities for dipeptides containing the aromatic amino acid L-phenylalanine. The screening procedure indicated glyCyl-L-proline hydrolase activity was reduced in biopsy specimens from patients with flattened intestinal mucosa. To explore this further, we established optimal assay conditions for hydrolase
INTRODUCTION
The mucosa of mammalian small intestine is rich in peptide hydrolases1 (EC 3.4 [1] ). The function of peptide hydrolysis in the intestinal mucosa is not established, but a role in the final phase of protein digestion has been postulated (2) . The discovery that a deficiency of disaccharidase activity in the human intestinal mucosa can cause disease (3) has raised the question of whether disturbances may occur as a result of analogous deficiency of peptide hydrolase activity (4) . There is preliminary evidence showing an impairment of the ability of intestinal mucosa of patients with glutensensitive enteropathy to catalyze the hydrolysis of certain polypeptides (5, 6) .
The present study was undertaken to characterize some aspects of peptide hydrolase activity of the human small intestine mucosa in health and disease. For this investigation, two new techniques were developed; one is a method that permits rapid screening of tissue extracts for hydrolase activity by use of high-voltage paper electrophoresis, the other is a method for quantitation of hydrolysis of dipeptides containing L-phenylalanine, L-tyrosine, or L-tryptophan. The application of these and other (7) methods to the study of intestinal biopsy specimens from human subjects revealed a deficiency of imidopeptide hydrolase (prolidase) activity' in three patients with subtotal villus atrophy.
1The term "peptide hydrolase" has been used in this METHODS Except for the compounds noted below, all of the amino acids, amino acid derivatives such as amides and esters, and dipeptides were obtained from a single commercial source.-Another company3 supplied glycyl-L-alanyl-L-phenylalanine, L-alanyl-L-phenylalanylglycine, and L-tyrosyl-L-alanyl-L-phenylalanine, and a third company 4 supplied L-phenylalanyl-Lproline, L-alanyl-L-phenylalanine amide, and L-alanyl-Lphenylalanine diketopiperazine. In every case the chemical was of the highest analytical grade offered by the company. In addition, each compound was tested for purity by subjecting 0.1 umole to high-voltage paper electrophoresis' at 56 v/cm for 45 min in 6.8%o formic acid (pH 1.9). In most cases a contamination by ninhydrin-reactive material of approximately 0.1% would have been detected. Impurities were seen only with glycyl L-phenylalanine, L-methionylglycine, L-alanyl-L-phenylalanylglycine, and L-tyrosyl-Lalanyl-L-phenylalanine. Electrophoresis of these compounds produced very faint spots corresponding to two or more of their components. We estimate that contamination was no greater than 0.3%. L-Amino acid oxidase from the snake Crotalhs adamantcus was obtained as the lyophilized venom 6 for phenylalanine assays. Absolute ethanol (99.5% by volume), USP reagent grade, was used in the assay of glycyl-L-proline hydrolase activity. All other chemicals were also of reagent grade. Water distilled in quartz vessels was used throughout the study. Reaction mixtures were incubated in a shaker water bath.
Biopsies of the small intestine mucosa of subjects fasted overnight were taken from the region of the ligament of Treitz with a multipurpose peroral biopsy instrument (8) , positioned under fluoroscopic control. Tissue specimens were transported on ice-cold aluminum foil, washed twice for 30 sec in 50 ml of cold isotonic (0.155 M) sodium chloride solution, freed of excess water by draining them on filter paper for approximately 20 sec, weighed, and homogenized within 15 min of the biopsy procedure in cold isotonic saline solution (0.3 ml/mg of tissue) with a ground glass microhomogenizer. Dilutions of the homogenates were made with cold isotonic saline solution. All assays for enzyme activity or protein content were performed in duplicate or triplicate, except in the few instances when there was insufficient tissue to do so.
Enzyme assay: hydrolases for phlenylalaninc-contaibing dipeptides. Quantitative measurements were made of the hydrolase activities for L-alanyl-L-phenylalanine, L-phenylalanyl-L-proline, and L-phenylalanylglycine. In each assay the amount of phenylalanine liberated was determined by an enzymatic spectrophotometric assay (9) . The standard hydrolase assay mixture contained 10 Amoles of dipeptide, 100 Amoles of Tris-maleate (pH 7.5, except in the assay for L-phenylalanyl-L-proline hydrolase where it was 6.0), enzyme, and other additions when indicated, in a total volume of 1.0 ml. The assay for L-alanyl-L-phenylalanine hydrolase was usually performed with approximately 10 To assay serum or red blood cells for L-alanyl-L-phenylalanine hydrolase activity, the procedure was modified slightly because these tissues have a comparatively low specific activity, and the excess protein interferes with the assay for phenylalanine. After addition of perchloric acid, the incubation mixture sat for 2-5 min, and then the precipitated protein was removed by centrifugation at 1600 g for 10 min. An aliquot of the supernatant solution was neutralized with KOH, and the rest of the procedure was carried out as described.
Phenylalanine determination. The phenylalanine content of the supernatant solution from the hydrolase assay was determined by the method of La Du and Michael (9) was present. A linear relation was observed between quantity of phenylalanine added to the cuvette and absorbance, over a range between 0 and 0.14,mole of phenylalanine. The absorbance was 0.8 when 0.14 umole of phenylalanine was present. In other studies we used the same procedure to determine the L-tyrosine or L-tryptophan released from dipeptides, except that absorbance readings were made at 330 m/A for L-tryptophan.
Enzyme assay: glycyl-L-proline hydrolase. The method of Josefsson and Lindberg (7) was used to assay glycyl-Lproline hydrolase activity. This method depends on the fact that the absorbance at 220 mu of a dipeptide in solution is greater than the absorbance of a solution of equivalent amounts of its constituent amino acids (Fig. 2) 11 ,000 g in an angle head centrifuge which was allowed to stop without braking. Approximately 1 ml of each supernatant solution was transferred to a dry, acid-washed quartz cuvette (1.0 cm light path), and the absorbance at 220 mls (Zeiss PMQ II spectrophotometer, slit width 0.34 mm) of an assay mixture was read against its corresponding blank mixture. Corrections were made for optical differences between cuvettes. The 15-min value was subtracted from the zero time value to obtain AA220. The quantity of dipeptide hydrolyzed was calculated from the value for AA2A= by use of a conversion factor. This factor was determined by preparing a series of solutions containing increasing amounts of glycyl-L-proline, sufficient quantities of glycine and L-proline to maintain the total amount of free and peptide-bound amino acid constant, heat-denatured enzyme (homogenate of intestinal mucosa), and the remaining constituents of the standard assay mixture. Ethanol was added and Am, was determined for each solution by reading the absorbance against the blank mixture described above. The conversion factor was derived from a graph of A220 as a function of amount of dipeptide in the original mixture. A unit of glycyl-L-proline hydrolase activity was defined as that amount of enzyme required to catalyze the cleavage of 1 mgomole of dipeptide in 15 min under the standard assay conditions. Specific activity was defined as enzyme units per milligram of protein.
Enzyme assay: alkaline phosphatase. Alkaline phosphatase activity was determined according to Bessey, Lowry, and Brock (13 0.01-ml samples were applied 2 cm apart along an origin to a Whatman 3MM electrophoresis paper strip, 46 X 160 cm. By use of multiple origins on a single strip, up to a maximum of four, many assays were performed in a single run (Fig. 3) . Appropriate amino acid and peptide standards (20 (14) , and developed at 77°C for 3-6 min. In contrast, addition of other compounds to the assay mixture resulted in a marked and continuous rise in absorbance (Fig. 5) . Therefore, the enzymatic spectrophotometric assay could not be used to determine the individual aromatic amino acids in the presence of:
L-tyrosine amide, L-tyrosyl-L-alanyl-L-phenylalanine, and the ethyl esters of phenylalanine, tyrosine, and tryptoplhan. We believe the difficulty is attributable to catalysis of hydrolysis of these compounds by enzymes in the snake veiniom. This hypothesis was proved in several instances by use of the paper electrophoresis technique to assess hydrolase activity in the venom. A mixture containing 8 fumoles of substrate, 80 umoles of sodium phosphate buffer (pH 6.5), and 0.2 ml of a water extract of venom (10 mg 'ml) (9) in a total volume of 1.0 ml was incubated for 1 hr at 370C. Two control incubation mixtures were prepared: one was identical with the assay mixture except that the venom extract was heated L-alanyl-L-phenylalanine. We observed only minimal splitting of L-alanyl-L-phenylalanine and L-phenylalanine amide and no detectable hydrolysis of glycyl-L-tyrosine, Properties of human intestinal hydrolases for phenylalanine-containing dipeptides tivity. L-Alanyl-L-phenylalanine and L-phenylalanylglycine hydrolases were chosen for comparison. In other studies we had found that rat intestinal mucosa was particularly rich in the former activity and relatively poor in the latter, and this proved true for man as well. In the rat the two enzyme activities could be partially separated by centrifugation or ion-exchange column chromatography and therefore appeared to be attributable to separate proteins. pH optima. The hydrolases for L-phenylalanylglycine and L-phenylalanyl-L-proline were most active at pH values 7.7 and 6.0, respectively (Fig. 6 ), and these were selected for the standard assays. L-Alanyl-L-phenylalanine hydrolase activity of human intestinal mucosa was relatively uninfluenced by pH changes over a wide range of values, and 7.5 was chosen for its standard assay.
Effects of incubation time and tissue concentration. The rate of liberation of phenylalanine from each dipeptide was linear with respect to time of incubation for at least 20 min (Fig. 7) , and 15 min was chosen for the standard assays. Reaction rate varied as a linear function of amount of mucosal homogenate added to the incubation mixture over the ranges shown in Fig. 8 .
Assays were carried out so that observed activities did not exceed the upper limits of these ranges.
Divalent cations. Although no divalent cations were added to the standard incubation mixtures for the three hydrolase assays, in a limited number of experiments we studied effects of divalent cations on two of the activities in human intestinal mucosa. At 10'imole/liter, EDTA reduced the rate of hydrolysis of L-alanyl L-phenylalanine by about 40%. This inhibition was comipletely prevented by 1.8 X 10' M ZnCI2. Similar observations were made with L-alanyl-L-phenylalanine hydrolase activity of rat intestinal mucosa. Experiments with rat intestinal mucosa showed that the addition of other divalent cations such as Co", Mg", Cu+, and Sn++ in the same concentrations as Zn++ either did not prevent, or only partially prevented, the inhibition caused by EDTA. Taken together, these experiments suggest, but do not prove, that both human and rat intestinal L-alanyl-L-phenylalanine hydrolases require Zn++ for optimal activity. Further experiments showed that at higher concentrations, and in the absence of EDTA, many of the divalent cations themselves can diminish L-alanyl-Lphenylalanine hydrolase activity of human intestinal mucosa. Thus, at 3 X 10-' mole/liter ZnCl2, CuCl2, and CoCl2 decreased the hydrolase activity 52, 26, and 44%, respectively, under standard assay conditions. Under the same conditions, MgCl2 did not affect activity.
Although, as described below, 10' M MnCl2 stimulated glycyl-L-proline hydrolase activity of human intestine, the same concentration of Mn++ did not influence the activity of L-phenylalanyl-L-proline hydrolase.
Intracelldlar localization. This was determined only for L-alanyl-L-phenylalanine hydrolase activity. When an homogenate of human intestinal mucosa in isotonic saline was centrifuged for 1 hr at 105,000 g, the resulting supernatant solution had the same activity per unit volume as did the original homogenate, indicating that the hvdrolase is in the soluble fraction of the cell.
Identification of reaction products. The amino acids liberated in each hydrolase assay were identified by their characteristic migration on high-voltage paper electrophoresis. Additional support for the characterization of liberated phenylalanine comes from the fact that it served as a substrate for the enzymatic spectrophotometric assay.
Properties of intestinal glycyl-L-proline hydrolase
The activity of glycyl-L-proline hydrolase of human intestinal mucosa was maximal at pH 7.5 (Fig. 6) . Rate of hydrolysis was constant for at least 20 min (Fig. 7) . The range over which hydrolase activity varied as a linear function of amount of tissue in the incubation mixture is shown in Fig. 8 . The activity was increased to varying extents, up to a maxium of 17%, by 10-' M MnCl2 in the incubation medium. Some divalent cations may react with peptides and produce changes in ultraviolet absorption which interfere with the Josefsson and Lindberg assay (7), but this did not occur with manganese and glycyl-L-proline. When MgCl2 replaced MnCI2 in the assay mixture, there was a moderate decrease in hydrolase activity.
In contrast to the L-alanyl-L-phenylalanine hydrolase activity of human small intestine mucosa, the glycyl-Lproline activity is not localized exclusively in the soluble fraction of the tissue. Thus, when a mucosal homogenate in isotonic saline was centrifuged for 1 hr at 105,000 g, the activity of the supernatant solution was 4700 U/ml, whereas the activity of the original homogenate was 7100 U/ml. We did not characterize the particles with which the unrecovered activity was associated.
Peptide hydrolase activities in small intestine mucosa of normal subjects High-voltage paper electrophoresis was used to estimate the activity of various peptide hydrolases in normal human intestinal mucosa. Under the assay conditions some peptides were completely hydrolyzed to their component amino acids, whereas others were only partially hydrolyzed (Fig. 9) . Hydrolytic activities for more complex substrates, such as tripeptides (Fig. 9) , and a dipeptide amide were also studied. Results of semiquantitative assays with 24 different substrates are summarized in Table I . The normal human intestinal mucosa contains hydrolase activities for many peptides, and the degree of activity varies markedly.
Quantitative determinations of the specific activities of the four peptide hydrolases selected for particular study are summarized in Table II . L-Alanyl-L-phenylalanine hydrolase activity was approximately 10-fold greater than the hydrolase activities for the other three substrates. With only a few exceptions, assays of individual biopsy specimens were performed in duplicate, and the values rarely differed by more than 10%. With one biopsy specimen activity of each hydrolase for the phenylalanine-containing dipeptides was determined in triplicate to assess reproducibility of the assay. Standard Fig. 9 a A study of glycyl-L-phenylalanine hydrolase activity. Adjacent columns (not shown) depicted the migration of authentic glycine and L-phenylalanine (brackets, 9 c). In columns 1 and 2 virtually no residual dipeptide was seen, and the component amino acids appeared, indicating complete hydrolysis of the substrate. Fig 9 b A similar study of peptide hydrolase activity for L-leucyl glycine. In this case, significant amounts of the dipeptide persisted in columns 1 and 2 after incubation. To estimate degree of hydrolysis, authentic samples of the individual amino acids in amounts equal to 259 of the tkmoles of the dipeptide originally present in columns 1 and 2 were applied to adjacent strips. We estimated that the amount of glycine or leucine liberated, in columns 1 and 2, was approximately twice that of the corresponding standard, and therefore that 50%o hydrolysis occurred. Fig. 9 c A study of the hydrolysis of glycyl-L-alanyl-L-phenylalanine. The amount of tripeptide decreased significantly after incubation, and four new spots appeared. These corresponded to each constituent amino acid and to L-alanyl-L-phenylalanine in their migration. No glycyl-L-alanine was seen. The results of these and of similar, related studies were consistent with the interpretation that enzymes in human intestinal mucosa catalyze hydrolysis of some tripeptides by acting initially on the N-terminal amino acid.
In Figs. a, b , and c, the activities in the normal and diseased mucosal specimens were essentially the same; however, quantities of normal and diseased mucosa used were chosen to contain equal L-alanine-L-phenylalanine hydrolase activities.
deviations from the mean were 1.6, 4.6, and 3. 1% of the mean for L-alanyl-L-phenylalanine, L-phenylalanylglycine, and L-phenylalanyl-L-proline hydrolases, respectively.
Intestinal peptide hydrolase activities of patients with flattening of the intestinal mucosa Initial screening. The paper electrophoresis technique was used to compare each of two patients (H.C. and K.G.), who had flattening of the intestinal mucosa, with a normal volunteer of corresponding age and sex for ability of intestinal mucosa to catalyze hydrolysis of the compounds listed in Table I 
Tripeptides and L-alanyl-L-phenylalanine amide
Substrate
Compounds detected after incubation Amount lase activity was selected for detailed study; the other activity has not yet been investigated further. Quantitative assays. We determined quantitatively intestinal hydrolase activity for glycyl-L-proline, L-phenylalanyl-L-proline, L-alanyl-L-phenylalanine, and L-phenylalanylglycine, and intestinal alkaline phosphatase activity in patients with flattening of the intestinal mucosa and in patients with various other intestinal abnormalities (Table II) . In the patients with intestinal disorders but without flattening of the intestinal mucosa, group B, the mean values for enzymatic activities (a)-(e) (Table II) were 63, 77, 84, 86, and 92% respectively, of the mean values for normal volunteers, group A. The difference was statistically significant (20) (P < 0.01) only for glyCyl-L-proline hydrolase. In the patients with flattening of the intestinal mucosa, group C, the mean values for the hydrolase activities for glyCyl-L-proline and L-phenylalanyl-L-proline were 14 and 31% of the mean normal values, respectively. The other two hydrolase activities were approximately 75% of their corresponding normal means, and the mean value for alkaline phosphatase activity was 22% of normal. These differences from normal were significant (P < 0.01) for each activity except L-alanyl-L-phenylalanine hydrolase. The mean values for group C were not only lower than normal but also 23, 40, 90, 82, and 24% of the mean values of group B for activities (a)-(e), respectively. The statistical significance of the differences of Fig. 9 . In both columns 1 and 2 significant amounts of residual glYCYI-Lproline were found after incubation. However, although liberated glycine was clearly visible in column 1, much less glycine was seen in column 2, indicating that the hydrolase activity was reduced in the specimen from the patient with flattening of the intestinal mucosa. Although an amount of proline comparable to that of glycine was liberated, the ability of the proline to produce a color with a ninhydrin stain is limited, and it was not seen in the present studies.
the mean values for groups B and C is given in Table II .
The results suggest that in group C the imidopeptide lhydrolase activities, (a) and (b), were reduced to a much greater extent than the other peptide hydrolase activities. To examine whether there was indeed a selective lowering of the imidopeptide hydrolase activities in group C, the ratios of the various activities weredetermined as shown in Table III . Values are given for the ratio of each imidopeptide hydrolase activity to the activity of each of the other peptide hydrolases (ratios 1 and 2 for glycyl-L-proline hydrolase, and ratios 4 and 5 for L-phenylalanyl-L-proline hydrolase) and to theactivity of alkaline phosphatase (ratios 3 and 6). For group B, the ratios were all somewhat lower than normal, but in no case was the difference from group A statistically significant (P < 0.01). For group C, the ratios of the activities of the two imidopeptide hydrolases to the other two peptide hydrolases (ratios 1, 2, 4, and 5) were all markedly and significantly below normal. Ratio 3 was somewhat reduced (P>0.1), and ratio 6 was not reduced at all, indicating that the reduction in alkaline phosphatase activity in group C equalled or exceeded the reduction in imidopeptide hydrolase activities. A similar comparison of the data for groups B and C established that in group C there was a significant selective reduction in glycyl-L-proline hydrolase activity, but there were insufficient determinations to establish the statistical validity of the selective reduction in L-phenylalanyl-L-proline hydrolase activity. Taken together, the results suggest that various intestinal disorders can produce a nonspecific reduction in a number of peptide hydrolase activities in the small bowel mucosa, but that the pathophysiological changes associated with flattening of the intestinal mucosa tend to produce a selectively greater reduction in the imidopeptide hydrolase activities.
We performed the following experiment to learn whether the difference in activity of glycyl-L-proline hydrolase of normal and diseased intestines is attributable to the presence of either an inhibitor of the enzyme in diseased gut or a stimulatory factor in normal gut.
Homogenates of intestinal mucosa from M.R. (normal volunteer) and H.C. (group C) were assayed individually and in combination. The results (Table IV) showed that the activities were additive and tended to exclude the presence of inhibitory or stimulatory factors.
Studies of several body fluids and erythrocytes
Human materials other than intestinal mucosa were assayed with each of the two new methods. L-Alanyl-Lphenylalanine hydrolase activity of blood was determined with the quantitative assay. In the presence of serum, hydrolysis varied as a linear function of incubation time for at least 15 min and of amount of serum up to 0.7 ml. For one normal subject activities in serum, plasma, and packed erythrocytes (centrifugation at 2500 g for 10 min) were 0.42, 0.42, and > 2.0 U/ml. respectively.
Activities of serum samples obtained on separate days from another normal subject were 0.50 and 0.57 U/ml.
Hvdrolase activities of gastric and duodenal aspirates from normal volunteers were studied with high-voltage paper electrophoresis. Gastric aspirate had no detectable activity for any of the compounds listed in Table I or for L-leucylglycine, N-carbobenzoxyglycyl-L-phenylalanine, or N-carbobenzoxy-L-alanyl-L-phenylalanine. Duodenal aspirate catalyzed hydrolysis of all the compounds tested with gastric aspirate, except for L-alanyl-L-phenylalanine diketopiperazine, L-carnosine, and L-phenylalanine amide. A rough comparison of homogenates of jejunal mucosa with duodenal aspirate revealed a disproportionately higher activity for N-carbobenzoxyglycyl-L-phenylalanine, N-carbobenzoxV-L-alanyl-L-phenylalanine, and L-leucyl-L-tyrosine hydrolysis in the duodenal aspirate.
DISCUSSION
The present studies were performed to characterize several peptide hydrolase activities of the mucosa of the Peptide Hydrolase Activities of Human Small Intestine Mucosa (21) . Human tissues shown to contain peptide hydrolase activities include small intestine mucosa, liver, and pancreas (23) . The role of peptide hydrolase activities in the intermediary metabolism of the nonintestinal tissues has not been precisely defined. It is not clear whether these hydrolases contribute to the catabolism of intracellular proteins, whether they digest peptides delivered to the cells by the blood, whether they catalyze the breakdown of par- (5, 6. 23, 29-33) . The present investigations were facilitated by development of a quantitative assay for hydrolases of peptides containing L-phenylalanine,9 and by use of a high-voltage paper electrophoresis technique to survey multiple peptide hydrolase activities in an individual biopsy specimen. In the quantitative hydrolase assay the amount of aromatic amino acid liberated from the peptide is determined with an enzymatic spectrophotometric method (9) in which the liberated amino acid is oxidized to its a-keto derivative with snake venom L-amino acid oxidase. The oxidase has an almost absolute requirement for both a free amino group and a free carboxyl group on the amino acid (34) , and this property was used in the past as the basis for a manometric assay for peptide hydrolase activity (35) . Our hydrolase assay can be used with many peptide substrates to measure accuratelv the hydrolysis of as little as 0.06 Mmole. This sensitivity compares favorably with that of the recently described hydrolase assay of Joseffson and Lindberg (7) which is not applicable to the study of dipeptides containing aromatic amino acids. The present assay can also be used to measure release of aromatic amino acids from many of their tripeptides.
The normal human intestinal mucosa contains many different peptide hydrolase activities (Table I) With glycyl-L-proline as the substrate, optimum activity of rabbit muscle prolidase (21) was observed at pH 7.7, and of purified swine kidney prolidase (22) at 8.0. Glycol-5-proline hydrolase activitv of human intestinal mucosa was greatest at pH /7.5. The pH optimum for L-phenylalanyl-L-proline hvdrolase activity was 6.0. Others (21) have shown that prolidase from several sources is activated by MIn+-. \We found that 9 The application of this assay to studies of hydrolases of peptides containing L-tryptophan or L-tyrosine will be described in a separate communication.
addition of AInCl2 to crude homogenates of human intestinal mucosa slightly increased glycyl-L-proline hydrolase activity, but not L-phenylalanyl-L-proline hydrolase activity.
We interpret our studies of patients with intestinal disease as showing that various disorders of the small intestine can produce a nonspecific reduction of at least the several mucosal peptide hydrolase activities we assayed. Flattening of the intestinal mucosa apparently leads to a more specific decrease in glycyl-L-proline hydrolase activity and probably in L-phenylalanyl-L-proline hy-drolase activitv as well. Since two of the three patients exhibiting this abnormality did not improve when fed a gluten-free diet, the marked reduction in imidopeptide hydrolase activity does not appear to be attributable to the underlying defect in gluten-sensitive enteropathy, but rather to the altered physiology that leads to flattening of the intestinal mucosa. Because a decrease in alkaline phosphatase activity tended to parallel the decrease in imidopeptide hydrolase activity, it is possible that both activities are located in the same organelle of the intestinal epithelial cell, and that their reduction reflects a pathologic change in that organelle. Thus, the imidopeptide hydrolases may. like alkaline phosphatase. be localized significantly in the brush border, and microvillus membrane abnormalities may account for the observed reductions. Our finding that more than half of the intestinal glycyl-L-proline hydrolase activity is associated with the particulate fraction of tissue homogenates is consistent with this conjecture. We must emphasize, however, that the present studies were not designed to establish the intracellular location of the peptide hydrolase activities studied. This would require the removal of sufficient quantities of intestinal mucosa to permit isolation of microvillus membranes, and, possibly, histochemical localization of the enzyme activities.
It is important to remember, too, that our studies, like analogous ones of other human intestinal enzymes, were carried out with homogenates of a complex tissue, and that these complexities impose some limitations on the hypotheses to be drawn from the results. Thus, the intestinal mucosa includes lining epithelial cells, inflammatory cells of the lamina propria, capillaries, and lacteals; it nmaN contain pancreatic enzymes absorbed or adsorbed from the intestinal lumen; and mucosal biopsy specimens may have closely associated bacteria. It is possible, therefore. that in the biopsy specimens from our patients wnith flattening of the mucosa, all the peptide hydrolase activities were equally reduced in the epithelial cells but that the inflammatory cells, which are usually found in increased numbers in a flattened mucosa, contain L-alanyl-L-phenylalanine and L-phenylalanylglycine lhydrolase activities, and that the increase in inflammatory cells resulted in an apparent specific lowering of the imidopeptide hydrolase activities. However, in at least one of the biopsy specimens from K.G. (group C) the lamina propria did not contain an abnormal number of inflammatory cells, and yet the changes in imidopeptide hydrolase activities in this specimen were comparable to those in specimens with excessive inflammatory cells.
It is also conceivable that contamination of the biopsy specimens by bacteria could have affected our results.
However, the biopsy specimens were washed carefully, and incubations were carried out for only 15 (21) . Under such circumstances brush border membrane disease might be associated with a greater reduction in prolidase activity than in the peptide hydrolase activities which could be derived from pancreatic secretion, and this could explain our findings.
Evidence has been presented suggesting that peptide hydrolase activities can be lost very rapidly from the mucosal cells of the mammalian small intestine (38, 39) . Wle examined this possibility experimentally with human mucosa, assaying hydrolase activities for L-alanyl-Lphenylalanine and L-phenylalanylglycine, and found that under the conditions of our studies less than 15% of these activities was lost into the surrounding medium in vitro. The low specific activity of imidopeptide hydrolase activities in human mucosa prevented us from carrying out similar studies for those activities. Thus, it is theoretically possible that our finding of a lower imidopeptide hydrolase activity in flattened intestinal mucosa could have resulted from a greater loss of this enzyme activity from the diseased mucosa than from the normal mucosa. If this should prove to be the case, and it seems unlikely to us, our finding would still reflect a fundamental difference between healthy and diseased mucosa.
One or more of the various problems just discussed apply to all studies of enzyme activities in human intestinal mucosa, including the ones related to disaccharidase activity. A rigorous approach to these problems would entail the isolation of individual epithelial cells, free of contaminating bacteria. To our knowledge no studies of hydrolytic activities in epithelial cells isolated from biopsy specimens of human intestinal mucosa have been reported vet.
The results of the present study are consistent with the findings by Crabb6 (5) and by Pittman and Pollitt (6) that intestinal mucosa from patients with glutensensitive enteropathy failed to catalyze release of proline from a peptic-trvptic digest of gliadin to the same extent as mucosa from normal subjects. If their observations are related to the deficiency of intestinal imidopeptide hrdrolase activity shown in our study, then, for the reasons discussed, their observations may reflect changes secondary to the flattening of the intestinal mucosa rather than a fundamental abnormality characteristic of gluten-sensitive enteropathy. Messer, Anderson, and Townley (30) obtained biopsies of duodenal mucosa from celiac patients and from control subjects and determined the peptide hydrolase activities for five dipeptides. a tripeptide, and L-leucinamide. The activities for the two groups of subjects were comparable. Glycyl-L-proline Xwas one of the dipeptides they used as a substrate, and thus their results differed from ours. However, their assay was not as precise as the one we used (7), they studied duodenal and not jejunal mucosa, and they studied intact tissue specimens rather than homogenates.
It is interesting to note that in none of the normal volunteers in our study was there a specific absence or reduction of any of the intestinal peptide hydrolase activities assayed. A more extensive evaluation of this problem is obviously required.
